Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Immune Environment in Glioblastoma (Feb 2023)
    • Korsmeyer Award 25th Anniversary Collection (Jan 2023)
    • Aging (Jul 2022)
    • Next-Generation Sequencing in Medicine (Jun 2022)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • Circadian Rhythm (Oct 2021)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Research letters
    • Letters to the editor
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Research letters
  • Letters to the editor
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI118430

Agmatine, a bioactive metabolite of arginine. Production, degradation, and functional effects in the kidney of the rat.

M J Lortie, W F Novotny, O W Peterson, V Vallon, K Malvey, M Mendonca, J Satriano, P Insel, S C Thomson, and R C Blantz

Department of Medicine, University of California, San Diego School of Medicine, La Jolla 92093, USA.

Find articles by Lortie, M. in: JCI | PubMed | Google Scholar

Department of Medicine, University of California, San Diego School of Medicine, La Jolla 92093, USA.

Find articles by Novotny, W. in: JCI | PubMed | Google Scholar

Department of Medicine, University of California, San Diego School of Medicine, La Jolla 92093, USA.

Find articles by Peterson, O. in: JCI | PubMed | Google Scholar

Department of Medicine, University of California, San Diego School of Medicine, La Jolla 92093, USA.

Find articles by Vallon, V. in: JCI | PubMed | Google Scholar

Department of Medicine, University of California, San Diego School of Medicine, La Jolla 92093, USA.

Find articles by Malvey, K. in: JCI | PubMed | Google Scholar

Department of Medicine, University of California, San Diego School of Medicine, La Jolla 92093, USA.

Find articles by Mendonca, M. in: JCI | PubMed | Google Scholar

Department of Medicine, University of California, San Diego School of Medicine, La Jolla 92093, USA.

Find articles by Satriano, J. in: JCI | PubMed | Google Scholar

Department of Medicine, University of California, San Diego School of Medicine, La Jolla 92093, USA.

Find articles by Insel, P. in: JCI | PubMed | Google Scholar

Department of Medicine, University of California, San Diego School of Medicine, La Jolla 92093, USA.

Find articles by Thomson, S. in: JCI | PubMed | Google Scholar

Department of Medicine, University of California, San Diego School of Medicine, La Jolla 92093, USA.

Find articles by Blantz, R. in: JCI | PubMed | Google Scholar

Published January 15, 1996 - More info

Published in Volume 97, Issue 2 on January 15, 1996
J Clin Invest. 1996;97(2):413–420. https://doi.org/10.1172/JCI118430.
© 1996 The American Society for Clinical Investigation
Published January 15, 1996 - Version history
View PDF
Abstract

Until recently, conversion of arginine to agmatine by arginine decarboxylase (ADC) was considered important only in plants and bacteria. In the following, we demonstrate ADC activity in the membrane-enriched fraction of brain, liver, and kidney cortex and medulla by radiochemical assay. Diamine oxidase, an enzyme shown here to metabolize agmatine, was localized by immunohistochemistry in kidney glomeruli and other nonrenal cells. Production of labeled agmatine, citrulline, and ornithine from [3H]arginine was demonstrated and endogenous agmatine levels (10(-6)M) in plasma ultrafiltrate and kidney were measured by HPLC. Microperfusion of agmatine into renal interstitium and into the urinary space of surface glomeruli of Wistar-Frömter rats produced reversible increases in nephron filtration rate (SNGFR) and absolute proximal reabsorption (APR). Renal denervation did not alter SNGFR effects but prevented APR changes. Yohimbine (an alpha 2 antagonist) microperfusion into the urinary space produced opposite effects to that of agmatine. Microperfusion of urinary space with BU-224 (microM), a synthetic imidazoline2 (I2) agonist, duplicated agmatine effects on SNGFR but not APR whereas an I1 agonist had no effect. Agmatine effects on SNGFR and APR are not only dissociable but appear to be mediated by different mechanisms. The production and degradation of this biologically active substance derived from arginine constitutes a novel endogenous regulatory system in the kidney.

Version history
  • Version 1 (January 15, 1996): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2023 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts